⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
globenewswire.com
NVO
Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight
globenewswire.com
FMS
BIIB
MDT
NVO
LLY
AZN
RDNT
LXRX
SNY
XRTX
RGEN
Inductive Bio Wins 3rd Consecutive AI Drug Discovery Benchmark
prnewswire.com
INDB
MRK
NVO
AMGN
HUYABIO International Delivers Significant Landmark Phase 3 Results in Advanced Melanoma
prnewswire.com
NVO
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
globenewswire.com
AMGN
AZN
JNJ
NVS
ABBV
AKBA
ARDX
CHNR
LLY
FGEN
GILD
GSK
NVO
PFE
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Pharmaceutical Regulatory Affairs in the Middle East and North Africa: Online Course Delivers Country-by-Country Regulatory Mastery Across the Region
globenewswire.com
NVO
Novo Nordisk’s denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
globenewswire.com
NVO
AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments
globenewswire.com
NVO
PFE
AZN
LLY
NVS
JNJ
MRK
SNY
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
prnewswire.com
NVO
EOLS
ABBV
CNXU